Stem cell reconstructive surgery involves the treatment of injured or damaged part of body. Stem cells are undifferentiated biological cells, which divide to produce more stem cells.
This report contains market size and forecasts of Stem Cell Reconstructive in Global, including the following market information:
Global Stem Cell Reconstructive Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Stem Cell Reconstructive market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Embryonic Stem Cell Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Stem Cell Reconstructive include Osiris Therapeutics, NuVasive, Cytori Therapeutics, Takeda (TiGenix), Cynata, Celyad, Medi-post, Anterogen and Molmed. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Stem Cell Reconstructive companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Stem Cell Reconstructive Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Stem Cell Reconstructive Market Segment Percentages, by Type, 2021 (%)
Embryonic Stem Cell
Adult Stem Cell
Global Stem Cell Reconstructive Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Stem Cell Reconstructive Market Segment Percentages, by Application, 2021 (%)
Hospitals
Research Institutes
Others
Global Stem Cell Reconstructive Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Stem Cell Reconstructive Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Stem Cell Reconstructive revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Stem Cell Reconstructive revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Osiris Therapeutics
NuVasive
Cytori Therapeutics
Takeda (TiGenix)
Cynata
Celyad
Medi-post
Anterogen
Molmed